Teva Canada commercialises Aermony RespiClick for bronchial asthma
Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society
Teva Inhalation Aerosol Approved by FDA for Children 4 and Over - Pharmaceutical Processing World
Teva Pharmaceutical Industries Ltd. - Did you know that 4.5 to 5.9 million Americans suffer from a severe form of #asthma called #eosinophilic asthma? Learn more about the condition in this infographic! #WorldAsthmaDay | Facebook
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
Buffy the asthma inhaler? Teva taps 'Vampire Slayer' actress to raise inhaler misuse awareness | Fierce Pharma
Teva Launches 2 New Digital Maintenance Inhalers
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
Teva Pharmaceutical touts real-world data on ProAir Digihaler for asthma (NYSE:TEVA) | Seeking Alpha
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva Pharmaceuticals on Twitter: "This month is National Asthma and Allergy Awareness Month and identifying and avoiding #asthma triggers is an important part of asthma management. Read and learn more here: https://t.co/CkL08njkXr #
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
Teva Announces FDA approval of AirDuo® Digihaler™
FDA approves Teva's asthma drug Cinqair - Philadelphia Business Journal
Teva buys Gecko to add device and app to asthma and COPD drugs
Teva Pharmaceuticals Europe - Home | Facebook
Teva Pharmaceuticals Europe - Home | Facebook
Teva launches digital asthma and COPD rescue inhaler in US | pharmaphorum